EMEA-000298-PIP01-08-M06

Key facts

Invented name
Pegasys
Active substance
peginterferon alfa-2a
Therapeutic area
Infectious diseases
Decision number
P/0143/2018
PIP number
EMEA-000298-PIP01-08-M06
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
  • Treatment of chronic hepatitis B
  • Treatment of chronic hepatitis C
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Roche Registration GmbH

Tel. +41 6168 79411
E-mail: global.paediatrics@roche.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating